期刊： EXPERT OPINION ON DRUG DELIVERY, 2021; 18 (8)
Introduction Compared with traditional cancer treatment methods, tumor-targeted immunotherapy can combine targeted therapy and immunotherapy with long......
期刊： EXPERT OPINION ON DRUG DELIVERY, ; ()
Background: To investigate the effects of insulin glargine injection given with a QS-P jet injector on the glucose profile using a professional mode f......
期刊： EXPERT OPINION ON DRUG DELIVERY, ; ()
Introduction: In selected patients with limited peritoneal metastasis (PM), favorable tumor biology, and a good clinical condition, there is an indica......
期刊： EXPERT OPINION ON DRUG DELIVERY, ; ()
Introduction Oral absorption of BCS IV drug benefits little from improved dissolution. Therefore, the absorption of BCS IV drug nanocrystals 'as a who......
期刊： EXPERT OPINION ON DRUG DELIVERY, ; ()
Introduction: The treatment of hard tissue defects, especially those of bone and cartilage, induced by infections or tumors remains challenging. Tradi......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2021; 18 (1)
Introduction Owing to the unique properties of graphene, including large specific surface area, excellent thermal conductivity, and optical absorption......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (8)
Introduction Development of new antimicrobials with ever 'better' bacterial killing has long been considered the appropriate response to the growing t......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (9)
Introduction To tackle challenges associated with traditional drug carriers, investigators have explored cells, cellular membrane, and macromolecular ......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (9)
Background Age-related macular degeneration (AMD) is a major cause of severe visual loss in elderly people. The treatments for dry AMD (dAMD) are seve......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (9)
Introduction Drug delivery systems with extended-release profiles are ideal in improving patient compliance with enhanced efficacy. To develop devices......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (10)
Background A novel nanoemulsion (CU/FU-LN) was developed as an oral 5-fluorouracil and curcumin co-delivery system for synergistic efficacy against li......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (10)
Introduction Most new drug candidates under development are poorly water-soluble, which are related to multiple pharmaceutical issues, increasing the ......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (10)
Introduction Everolimus (EVR) has been approved for the treatment of various advanced cancers and its indications are increasingly expanding. Therefor......
期刊： EXPERT OPINION ON DRUG DELIVERY, 2020; 17 (6)
Introduction: Colorectal cancer (CRC), the third-most common malignancy, has high morbidity and mortality. Oral nanotherapeutics have emerged as a pro......
